Skip to main content
Novartis
language-selector-globe Austria | de
Standort wählen
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Austria
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Über Uns 
      • Was wir tun 
        • Unsere Werte 
      • Geschichte 
        • Mehr als 75 Jahre Novartis in Österreich 
      • Forschung & Entwicklung 
      • Management 
      • Standorte in Österreich 
      • Unsere Strategie 
      • Diversity and Inclusion 
      • Arbeiten bei Novartis Österreich 
      • Produkte 
      Über uns Über Uns
    • Betroffene & Angehörige 
      • Unser Versprechen an Patientinnen und Patienten 
      • Patient Engagement 
        • Diabetisches Makulaödem (DMÖ) 
        • Brustkrebs 
        • Altersbedingte Makuladegeneration (AMD) 
        • Erblich bedingte Netzhautdystrophien (IRD) 
        • Webseiten & Apps 
      • Erkrankungen & Therapien 
        • Atemwegserkrankungen 
        • Augenerkrankungen 
        • Dermatologie 
        • Hämatologie 
        • Herz-Kreislauf-Erkrankungen 
        • Onkologie 
        • Rheumatologie 
        • Transplantation 
      • Produkte 
        • Innovative Medikamente 
        • Generika & Biosimilars 
        • Gen & Zelltherapien 
        • Produkte von A-Z 
      • Nebenwirkungen melden 
      • Klinische Studien 
        • Allgemeines 
        • Wissenswertes zu klinischen Studien 
        • Aktuelle Studien 
          • Chronische Myeloische Leukämie in der chronischer Phase (CML-CP): CABL001A2302 
        • Fachausdrücke 
        • Häufig gestellte Fragen zur Studienteilnahme 
        • Onkologische Studien 
      • Fragen & Nebenwirkungen 
        • Meine Fragen - medizinischen Informationsdienst von Novartis 
        • Meine Fragen - Arzt 
        • Meine Fragen - Apotheker 
      • Patientenportal 
      Teaser Patient*innen & Angehörige 280px Betroffene & Angehörige
    • Fachkreise 
      • Serviceportal 
      • Produkte 
      • Novartis Pipeline 
      • Nebenwirkungen melden 
      • Aktuelle Klinische Studien 
      • Novartis Clinical Trials 
      • Terminanfrage 
      Teaser Fachkreise 280px Fachkreise
    • Nachhaltigkeit 
      • Unternehmensethik 
        • Offenlegungen 
      • Zugang zu Medikamenten 
      • Umwelt & Gesellschaft 
      • Ethik, Risiko und Compliance 
        • SpeakUp 
      Nachhaltigkeit Nachhaltigkeit
    • Medien 
      • Pressemitteilungen 
      • Geschichten 
      • Unternehmenspublikationen 
      • Bildmaterial 
      • Medienkontakt 
    • Kontakt 
    • Karriere 
      • Jobsuche 
      • Arbeiten bei Novartis Österreich 
        • Sommer-/Ferialpraktikum 2024 
      • Mitarbeitende 
      • Karriere-Programme 
      • Lehre 
      • Meet the teams 
      Teaser Karriere 525x280px Karriere
    Banner Novartis Medien Startseite
  1. Home
  2. Karriere
  3. Jobsuche
  • Sort by Sort ascending
  • Positionsbezeichnung
  • Site
  • Standort
  • Division
  • Business Sort descending
  • Functional Area
  • Erscheinungsdatum
Positionsbezeichnung Site Standort Division Business Sort descending Functional Area Erscheinungsdatum
Associate Submission Manager Hyderabad (Office) Indien Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) Indien Biomedical Research Research & Development Aug 12, 2024
Business Data Analyst II Hyderabad (Office) Indien Biomedical Research Data and Digital Sep 11, 2024
Associate Submission Manager Hyderabad (Office) Indien Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) Indien Biomedical Research Research & Development Aug 12, 2024
BR Submission Management, Lead Hyderabad (Office) Indien Biomedical Research Research & Development Sep 19, 2024
BR Submission Management, Specialist Hyderabad (Office) Indien Biomedical Research Research & Development Sep 19, 2024
Laboratorijski analitik (m/ž/d) Ljubljana Slowenien Quality Okt 10, 2024
Associate Submission Manager Hyderabad (Office) Indien Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) Indien Biomedical Research Research & Development Aug 12, 2024
Clinical Data Specialist II Hyderabad (Office) Indien Biomedical Research Research & Development Jul 10, 2024
Clinical Data Specialist I Hyderabad (Office) Indien Biomedical Research Research & Development Jul 10, 2024
Associate Submission Manager Hyderabad (Office) Indien Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) Indien Biomedical Research Research & Development Aug 12, 2024
Senior Specialist - Automation Engineer Sasayama Japan Operations Research & Development Jul 16, 2024
Associate Submission Manager Hyderabad (Office) Indien Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) Indien Biomedical Research Research & Development Aug 12, 2024
Associate Submission Manager Hyderabad (Office) Indien Biomedical Research Research & Development Aug 12, 2024
Senior Accountant, Tax Shanghai (Shanghai) China Finance Corporate Audit und Finanzen Aug 29, 2024
Financial Analyst - SoD Ops Hyderabad (Office) Indien Finance Corporate Audit und Finanzen Sep 17, 2024
Associate Director, US Federal and State Tax Reporting East Hanover USA Finance Corporate Audit und Finanzen Sep 06, 2024
Corporate Tax Manager Amiria Ägypten Finance Corporate Audit und Finanzen Mai 31, 2024
Global Digital FRA Automation Lead Hyderabad (Office) Indien Finance Corporate Audit und Finanzen Jun 20, 2024
Associate Director ERC Risk&Operations, Corporate Functions Selangor Malaysia Ethics Risk & Compliance Corporate Legal & Intellectual Property & Compliance Aug 29, 2024
Juristisches Volontariat – Novartis Corporate Functions Basel (City) Schweiz Legal Corporate Others Sep 26, 2024
Tax Manager m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Deutschland Finance Corporate Audit und Finanzen Okt 16, 2024
Associate Director, M&A Planning & Integration East Hanover USA Finance Corporate Audit und Finanzen Okt 17, 2024
Vice President, Head of R&D Legal, Americas Cambridge (USA) USA Legal Corporate Legal & Intellectual Property & Compliance Okt 17, 2024
Executive Director, R&D Legal and FDA Regulatory Legal Lead East Hanover USA Legal Corporate Legal & Intellectual Property & Compliance Okt 17, 2024
Associate Director, SUSE Linux Administrator Prague Tschechische Republik Operations Corporate Technology Transformation Sep 23, 2024
Director, Sustainability & ESG Strategy (Health Equity / Access focus) Basel (City) Schweiz Corporate Affairs Corporate BD&L & Strategic Planning Okt 15, 2024
Expert Analyst – Management Reporting Prague Tschechische Republik Finance Corporate Audit und Finanzen Okt 08, 2024
Manager- Data Privacy Review and Remediation Selangor Malaysia Ethics Risk & Compliance Corporate Legal & Intellectual Property & Compliance Okt 14, 2024
Tax Specialist Mumbai (Head Office) Indien Finance Corporate Audit und Finanzen Okt 20, 2024
Financial IT Compliance Senior Specialist London (The Westworks) Vereinigtes Königreich Finance Corporate Audit und Finanzen Okt 25, 2024
Financial IT Compliance Manager London (The Westworks) Vereinigtes Königreich Finance Corporate Audit und Finanzen Okt 25, 2024
BPA Manager - Global Process Owner Hyderabad (Office) Indien Finance Corporate Audit und Finanzen Okt 24, 2024
Associate Director, Political Affairs & Insights Washington, DC USA Corporate Affairs Corporate Communications & Public Affairs Okt 22, 2024
Senior Product Manager, Digital Finance Barcelona Gran Vía Spanien Finance Corporate Audit und Finanzen Okt 22, 2024
IT Strategic Business Partner US&I (Salesforce) Barcelona Gran Vía Spanien Operations CTS Technology Transformation Okt 01, 2024
Sr. Spec. DDIT IES NetSec Engg Hyderabad (Office) Indien Operations CTS Technology Transformation Apr 16, 2024
Sr. Spec. DDIT IES Cloud Engineering Hyderabad (Office) Indien Operations CTS Technology Transformation Apr 16, 2024
Assoc. Dir. DDIT ISC Ent Arch Digit Sec Hyderabad (Office) Indien Operations CTS Technology Transformation Apr 16, 2024
Assoc. Dir. DDIT ISC VulnSvcs role Hyderabad (Office) Indien Operations CTS Technology Transformation Apr 17, 2024
Sr. Bus. Analyst DDIT US&I CPM Hyderabad (Office) Indien Operations CTS Technology Transformation Apr 17, 2024
Sr. Spec. DDIT ISC SecOps IAM Hyderabad (Office) Indien Operations CTS Technology Transformation Apr 17, 2024
Mgr. DDIT Svc.Mgt China Dalian (Liaoning Province) China Operations CTS Technology Transformation Apr 21, 2024
Sr. Mgr. DDIT Svc.Mgt CN Data Platf Dalian (Liaoning Province) China Operations CTS Technology Transformation Apr 21, 2024
Sr. Mgr. DDIT Sol.Del. China Data Dalian (Liaoning Province) China Operations CTS Technology Transformation Apr 21, 2024
Sr. Spec. DDIT IES NW Engineering Hyderabad (Office) Indien Operations CTS Technology Transformation Apr 22, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 42
  • › Next page

Novartis Österreich

Novartis entdecken
  • Über Uns
  • Betroffene & Angehörige
  • Fachkreise
  • Medien
  • Karriere
Medienbereich
  • Pressemitteilungen
  • Geschichten
Unser Portfolio
  • Arzneimittel der Novartis
Weitere Novartis Websites
  • Healthcare Professional Resources
  • Global site
Footer Bottom
© 2024 Novartis Pharma GmbH
  • Datenschutzerklärung
  • Nutzungsbedingungen
  • Über Cookies
  • Impressum
  • Cookie-Einstellungen
  • Barrierefreiheit im Internet
  • Site Map
Novartis Site Directory
Diese Website richtet sich an Personen in Österreich.